Russia terrified watching monuments destroyed in Palmyra — culture ministerRussian Politics & Diplomacy January 21, 17:08
Russian bombers deliver successfully strikes on terrorists' facilities in SyriaWorld January 21, 15:39
Denmark uses Russian data in its application for expanding shelf — ministerBusiness & Economy January 21, 15:15
Agreement on bases in Syria to serve strengthening of stability in Middle East — MPRussian Politics & Diplomacy January 20, 21:18
Trump's inaugural address: When America is united, America is totally unstoppableWorld January 20, 20:57
Hermitage chief: New Palmyra destruction comes across as militants' vengeanceRussian Politics & Diplomacy January 20, 20:29
Russia's first deputy PM wants to keep current tax system for next political cycleBusiness & Economy January 20, 19:53
Russia’s Shipulin clinches gold in 20km individual race of IBU World Cup stage in ItalySport January 20, 19:18
Prominent Russian adventurer Konyukhov to take samples from Mariana Trench floorSociety & Culture January 20, 19:15
ST. PETERSBURG, January 20. /TASS/. The US pharmaceuticals producer Pfizer will launch a joint production with St. Petersburg-based scientific and technological pharmaceutical company Polysan, a source familiar with the matter told TASS, adding that the sides are expected to sign the agreement in end-January.
"In end-January an agreement will be signed on production of Pfizer medicines in St. Petersburg and its localization. At the same time a joint production with Polysan pharm producer will be announced," the source said.
An official in St. Petersburg confirmed to TASS such an agreement is being prepared, saying that the signing is planned for January 25.
A representative of Polysan said when commenting the information that the company’s policy "is aimed at development of local pharmaceutical industry, including via cooperation with leading global pharma producers."
Polysan has manufacturing plants in St. Petersburg and Belgorod. In St. Petersburg, the company produces 4 its own brands of medicines, as well as a neurological drug within partnership with German Stada. In 2015, Polysan signed a 10-year agreement with German pharmaceuticals giant Bayer.
Polysan products are supplied to all regions in Russia, to the former CIS countries, South East Asia, Latin America and Mongolia.